Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (431-440 of 453) with videos related to

Pageof 46
Sort By:
Neurosurgery|June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain TumorsMary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D Brown, Vinai Gondi, Stephanie Pugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
AJNR. American Journal of Neuroradiology|December 27, 2024
ReplyBenjamin M Ellingson, Francesco Sanvito, Whitney B Pope, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Central nervous system cancersSteven S Brem, Philip J Bierman, Henry Brem, et al.
Neuro-Oncology|April 28, 2025
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiativeOgechukwu A Asogwa, Linda Dirven, Tobias Walbert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 46

Showing results (431-440 of 453) with videos related to

Sort By:
Pageof 46
Neurosurgery|June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain TumorsMary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D Brown, Vinai Gondi, Stephanie Pugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
AJNR. American Journal of Neuroradiology|December 27, 2024
ReplyBenjamin M Ellingson, Francesco Sanvito, Whitney B Pope, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Central nervous system cancersSteven S Brem, Philip J Bierman, Henry Brem, et al.
Neuro-Oncology|April 28, 2025
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiativeOgechukwu A Asogwa, Linda Dirven, Tobias Walbert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 46